Different histological types of active intraplaque calcification underlie alternative miRNA-mRNA axes in carotid atherosclerotic disease.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 25 04 2019
accepted: 26 08 2019
revised: 14 08 2019
pubmed: 12 9 2019
medline: 26 2 2020
entrez: 12 9 2019
Statut: ppublish

Résumé

Arterial calcification is an actively regulated process, with different morphological manifestations. Micro-RNAs emerged as potential regulators of vascular calcification; they may become novel diagnostic tools and be used for a finest staging of the carotid plaque progression. The present study aimed at characterizing the different miRNA-mRNA axes in carotid plaques according to their histological patterns of calcification. Histopathological analysis was performed on 124 retrospective carotid plaques, with clinical data and preoperatory angio-CT. miRNA analysis was carried out with microfluidic cards. Real-time PCR was performed for selected miRNAs validation and for RUNX-2 and SOX-9 mRNA levels. CD31, CD68, SMA, and SOX-9 were analyzed by immunohistochemistry. miRNA levels on HUVEC cells were analyzed for confirming results under in vitro osteogenic conditions. Histopathological analysis revealed two main calcification subtypes of plaques: calcific cores (CC) and protruding nodules (PN). miRNA array and PCR validation of miR-1275, miR-30a-5p, and miR-30d indicated a significant upregulation of miR-30a-5p and miR-30d in the PN plaques. Likewise, the miRNA targets RUNX-2 and SOX-9 resulted poorly expressed in PN plaques. The inverse correlation between miRNA and RUNX-2 levels was confirmed on osteogenic-differentiated HUVEC. miR-30a-5p and miR-30d directly correlated with calcification extension and thickness at angio-CT imaging. Our study demonstrated the presence of two distinct morphological subtypes of calcification in carotid atheromatous plaques, supported by different miRNA signatures, and by different angio-CT features. These results shed the light on the use of miRNA as novel diagnostic markers, suggestive of plaque evolution.

Identifiants

pubmed: 31506771
doi: 10.1007/s00428-019-02659-w
pii: 10.1007/s00428-019-02659-w
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-316

Références

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1177-8
pubmed: 10807728
Trends Cardiovasc Med. 2012 May;22(4):93-8
pubmed: 23040839
Biomed Res Int. 2015;2015:795672
pubmed: 25883974
J Am Coll Cardiol. 2005 Oct 18;46(8):1507-15
pubmed: 16226176
Open Access Med Stat. 2012 Apr 13;2012(2):21-31
pubmed: 24738042
AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1505-11
pubmed: 15956522
Circ Res. 2005 May 13;96(9):930-8
pubmed: 15890980
J Biomech. 2014 Mar 3;47(4):859-69
pubmed: 24491496
J Am Heart Assoc. 2012 Dec;1(6):e003905
pubmed: 23316327
Cardiovasc Res. 2015 Dec 1;108(3):377-86
pubmed: 26084310
Circ Res. 2013 Mar 29;112(7):1073-84
pubmed: 23538277
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Circulation. 2003 Nov 18;108(20):2505-10
pubmed: 14581408
Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H619-28
pubmed: 22777419
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):724-36
pubmed: 24558104
Ann Vasc Surg. 2017 Oct;44:336-342
pubmed: 28479433
World J Stem Cells. 2014 Nov 26;6(5):540-51
pubmed: 25426251
Stem Cell Res Ther. 2017 Apr 26;8(1):99
pubmed: 28446225
Thromb Haemost. 2012 Apr;107(4):619-25
pubmed: 22370758
BMC Cardiovasc Disord. 2012 Feb 15;12:7
pubmed: 22336469
Circ Res. 2013 Jun 21;113(1):72-7
pubmed: 23616621
Eur Heart J. 2017 Jun 14;38(23):1801-1804
pubmed: 26546599
PLoS One. 2013;8(3):e58796
pubmed: 23533592
Acta Pharmacol Sin. 2018 Jul;39(7):1073-1084
pubmed: 29877320
Front Endocrinol (Lausanne). 2012 Aug 06;3:95
pubmed: 22888324
J Immunol. 2015 Feb 15;194(4):1916-27
pubmed: 25601927
Circulation. 1995 Sep 1;92(5):1355-74
pubmed: 7648691
J Vasc Surg. 2015 Nov;62(5):1245-50.e1
pubmed: 26238333
J Mol Endocrinol. 2016 Jul;57(1):33-43
pubmed: 27154547

Auteurs

Francesco Vasuri (F)

Clinical and Surgical Pathology, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, 40138, Bologna, Italy.

Carmen Ciavarella (C)

Clinical and Surgical Pathology, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, 40138, Bologna, Italy.

Silvia Fittipaldi (S)

Clinical and Surgical Pathology, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, 40138, Bologna, Italy.

Rodolfo Pini (R)

Vascular Surgery, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, Bologna, 40138, Italy.

Andrea Vacirca (A)

Vascular Surgery, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, Bologna, 40138, Italy.

Mauro Gargiulo (M)

Vascular Surgery, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, Bologna, 40138, Italy.

Gianluca Faggioli (G)

Vascular Surgery, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, Bologna, 40138, Italy.

Gianandrea Pasquinelli (G)

Clinical and Surgical Pathology, Department of Specialty, Diagnostic and Experimental Medicine, S.Orsola-Malpighi Hospital, University of Bologna, via Massarenti 9, 40138, Bologna, Italy. gianandr.pasquinelli@unibo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH